When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?

Am J Transplant. 2016 Feb;16(2):727. doi: 10.1111/ajt.13567. Epub 2016 Jan 4.

Authors

N Kamar^{1

2

3}, O Marion¹, J Izopet^{2

3

4}

Affiliations

¹ Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.
² INSERM U1043, IFR-BMT, CHU, Purpan, Toulouse, France.
³ Université Paul Sabatier, Toulouse, France.
⁴ Laboratory of Virology, CHU Purpan, Toulouse, France.

PMID: 26729540
DOI: 10.1111/ajt.13567

No abstract available

Keywords: clinical research/practice; infection and infectious agents; infectious disease; liver disease; viral: hepatitis.

Publication types

Letter
Comment

MeSH terms

Female
Hepatitis E / classification*
Hepatitis E virus / isolation & purification*
Humans
Liver Transplantation / adverse effects*
Viral Load*